Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-188189
Filing Date
2022-07-06
Accepted
2022-07-06 06:04:29
Documents
2
Period of Report
2022-07-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d368939d6k.htm 6-K 21395
2 GRAPHIC g368939g0706071042575.jpg GRAPHIC 7485
  Complete submission text file 0001193125-22-188189.txt   32994
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 221067332
SIC: 2834 Pharmaceutical Preparations